Platelet activating factor-acetylhydrolase (PAF-AH) activity and HDL levels, but not PAF-AH gene polymorphisms, are associated with successful aging in Sicilian octogenarians

Aging Clinical and Experimental Research
Salvatore CampoAntonino Saitta

Abstract

Aging is associated with an increased risk of developing atherosclerosis. Subjects over 80 years of age without cardiovascular disease provide a model to investigate the protective factors increasing their resistance to atherosclerotic disease. Platelet-activating factor acetylhydrolase (PAF-AH) is an enzyme associated with low density lipoprotein (LDL) and high density lipoprotein (HDL) inactivating platelet-activating factor (PAF) and preventing LDL oxidation by hydrolysis of oxidized phospholipids. The aim of the present study was to evaluate the contribution of the PAFAH gene Arg92His, Ile198Thr and Ala379Val polymorphisms to resistance toward developing cardiovascular events in healthy Sicilian octogenarians. Distribution of PAF-AH genotypes and activity, and biochemical parameters, were compared between 100 octogenarians and 200 healthy adults. The individuals in the elderly group displayed significantly higher levels of HDL-C (p<0.001) and plasma (p<0.001) and HDL (p<0.001) PAF-AH activity. Analysis of PAFAH genotype distributions showed no significant differences between octogenarians and controls. No differences among PAF-AH genotypes with respect to plasma and HDL PAF-AH activity were found in either group. Our result...Continue Reading

References

Aug 1, 1992·Stroke; a Journal of Cerebral Circulation·K SatohS Mizuno
Jul 1, 1991·European Journal of Epidemiology·A HofmanF A van den Ouweland
Mar 1, 1990·Age and Ageing·M Nikkilä, J Heikkinen
Apr 6, 1989·The New England Journal of Medicine·D SteinbergJ L Witztum
Jul 10, 1987·Science·J W Rowe, R L Kahn
Sep 1, 1995·The Journal of Clinical Investigation·S AzharE Reaven
Sep 30, 1994·Science·E S Lander, N J Schork
Dec 20, 1996·Chemistry and Physics of Lipids·W JiraA Schramm
Mar 1, 1997·Coronary Artery Disease·C NapoliG Palumbo
Jul 30, 1997·Biochemical and Biophysical Research Communications·Y Yamada, M Yokota
Jan 22, 1998·Biochemical and Biophysical Research Communications·R BellI S Gloger
Mar 5, 1998·JAMA : the Journal of the American Medical Association·L P FriedJ M Gardin
Apr 30, 1998·Physiological Reviews·K B Beckman, B N Ames
Sep 16, 1998·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·J LykkesfeldtB N Ames
May 16, 2000·Clinica Chimica Acta; International Journal of Clinical Chemistry·T KosakaK Mizuno
Oct 12, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·G TheilmeierP Holvoet
Apr 13, 2001·Journal of the American Geriatrics Society·G L BurkeUNKNOWN CHS Collaborative Research Group
Mar 8, 2002·Atherosclerosis·Jerzy-Roch NoferArnold von Eckardstein
Jan 28, 2003·Progress in Lipid Research·Ken KarasawaMorio Setaka
Mar 22, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Hiroshi NotoKazuhisa Tsukamoto
Oct 21, 1994·Science

❮ Previous
Next ❯

Citations

May 28, 2010·Current Atherosclerosis Reports·Shawn Ragbir, John A Farmer
Mar 28, 2012·Experimental Gerontology·Giuseppe MandraffinoAntonino Saitta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.